U.S. Markets closed

Aesthetic Medical International Holdings Group Limited (AIH)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
5.74+0.51 (+9.75%)
At close: 12:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close5.23
Open5.21
Bid5.68 x 4000
Ask5.81 x 1000
Day's Range5.21 - 5.88
52 Week Range3.81 - 10.66
Volume61,477
Avg. Volume61,215
Market Cap135.538M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.99
  • Aesthetic Medical International Holdings Group Limited to Host Third Quarter 2020 Earnings Conference Call at 8:00 am ET on November 30, 2020
    GlobeNewswire

    Aesthetic Medical International Holdings Group Limited to Host Third Quarter 2020 Earnings Conference Call at 8:00 am ET on November 30, 2020

    Shenzhen, China, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announces that the Company will host its earnings conference call on Monday, November 30, 2020 at 8:00 am Eastern Time (5:00 am Pacific Time/ 9:00 pm Beijing Time) to discuss the Company’s financial results of the third quarter ended September 30, 2020. To attend this earnings conference call, please use the information below for either dial-in access or webcast access. When prompted, please reference “Aesthetic Medical International Holdings Group Limited”Conference Call Date:November 30, 2020 Time:8:00 am ET, U.S. International Toll Free:United States: +1 888-346-8982 Canada: +1 855-669-9657 Mainland China: +86 400-120-1203 Hong Kong: +852 800-905-945 International:International: +1 412-902-4272 Conference ID:Aesthetic Medical International Holdings Group Limited Please dial in at least 15 minutes before the commencement of the call to ensure timely participation. For those unable to participate, an audio replay of the conference call will be available from approximately one hour after the end of the live call until December 7, 2020. The dial-in for the replay is +1 877-344-7529 within the United States or +1 412-317-0088 internationally. The replay access code is 10150230.A live and archived webcast of the call will also be available on AIH's website at: https://ir.aihgroup.net/. Please log in at least 10 minutes prior to the conference call in order to download the applicable audio software.About Aesthetic Medical International Holdings Group LimitedAIH, known as “Peng’ai” in China, is a leading provider of aesthetic medical services in China. AIH operates through treatment centers that spread across major cities in mainland China, and also has presence in Hong Kong and Singapore. Leveraging over 20 years of clinical experience, AIH provides one-stop aesthetic service offerings, including surgical aesthetic treatments, non-surgical aesthetic treatments, and general medical services and other aesthetic services. According to certain third party industry consultant, AIH was the third-largest private aesthetic medical services provider in China in terms of revenue in 2018. For more information regarding the Company, please visit: https://ir.aihgroup.net/.Safe Harbor StatementThis press release contains “forward-looking statements.” These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to” and similar statements. Statements that are not historical facts, including statements about the Company’s beliefs, plans and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. These risks and uncertainties and others that relate to the Company’s business and financial condition are detailed from time to time in the Company’s SEC filings, and could cause the actual results to differ materially from those contained in any forward-looking statement. These forward-looking statements are made only as of the date indicated, and the Company undertakes no obligation to update or revise the information contained in any forward-looking statements, except as required under applicable law.Investor Relations ContactFor investor and media inquiries, please contact:Aesthetic Medical International Holdings Group LimitedEmail: ir@pengai.com.cnAscent Investor Relations LLCMs. Tina XiaoTel: (917) 609-0333Email: tina.xiao@ascent-ir.com

  • Aesthetic Medical International Holdings Group Limited Enters into Strategic Cooperation Agreement with Chengdu Meb Network Technology Co., Ltd.
    GlobeNewswire

    Aesthetic Medical International Holdings Group Limited Enters into Strategic Cooperation Agreement with Chengdu Meb Network Technology Co., Ltd.

    Shenzhen, China, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (the “Company” or Nasdaq: AIH), a leading provider of aesthetic medical services in China, today announces it has entered into a strategic cooperation agreement (the “Agreement”) with Chengdu Meb Network Technology Co., Ltd. (“Meb”), a leading social community platform in China connecting consumers, professionals and medical institutions in the aesthetics medical industry. Pursuant to the Agreement, the Company will become a member of Meb’s multi-channel network, allowing more consumers on Meb’s platform to have access to the Company’s services. Meb will provide various marketing services to the Company, including providing marketing trainings to the Company’s staff, allowing the Company to use Meb’s online promotional tools, and optimizing the operation of the Company’s social media platforms.Dr. Zhou Pengwu, the Chairman and CEO of the Company, commented, “We are excited about signing the Agreement with Meb. Meb and we share the same core value: bringing beauty, health and confidence to our customers through our services. This move marks an in-depth collaboration between the Company and Meb, and enables us to work together to provide high quality services to our customers, and to build and maintain a benign environment in the aesthetics medical industry in China.”About Aesthetic Medical International Holdings Group LimitedAIH, known as “Peng’ai” in China, is a leading provider of aesthetic medical services in China. AIH operates through treatment centers that spread across major cities in mainland China, and also has presence in Hong Kong and Singapore. Leveraging over 20 years of clinical experience, AIH provides one-stop aesthetic service offerings, including surgical aesthetic treatments, non-surgical aesthetic treatments, and general medical services and other aesthetic services. According to certain third party industry consultant, AIH was the third-largest private aesthetic medical services provider in China in terms of revenue in 2018. For more information regarding the Company, please visit: http://ir.aihgroup.net/.Safe Harbor StatementThis press release contains “forward-looking statements.” These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to” and similar statements. Statements that are not historical facts, including statements about the Company’s beliefs, plans and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. These risks and uncertainties and others that relate to the Company’s business and financial condition are detailed from time to time in the Company’s SEC filings, and could cause the actual results to differ materially from those contained in any forward-looking statement. These forward-looking statements are made only as of the date indicated, and the Company undertakes no obligation to update or revise the information contained in any forward-looking statements, except as required under applicable law.Investor Relations ContactFor investor and media inquiries, please contact:Aesthetic Medical International Holdings Group LimitedEmail: ir@pengai.com.cnAscent Investor Relations LLCMs. Tina XiaoTel: (917) 609-0333Email: tina.xiao@ascent-ir.com

  • GlobeNewswire

    Aesthetic Medical International Holdings Group Limited Announces US$6.0 Million Share Repurchase Program

    Shenzhen, China, Oct. 13, 2020 (GLOBE NEWSWIRE) -- Aesthetic Medical International Holdings Group Limited (the “Company”) (NASDAQ: AIH), a leading provider of aesthetic medical services in China, today announced that its board of directors has authorized a share repurchase program under which the Company may repurchase up to US$6.0 million worth of its American depositary shares over the next 12-month period, effective until October 12, 2021, pursuant and subject to applicable laws and the Company’s securities trading policy. All factors, including, but not limited to, trading price, trading volume and general market conditions, along with the Company’s working capital requirements and general business conditions shall be taken into account when determining the timing, volume and conditions of the share repurchases under the share repurchase program. The Company’s share repurchases may be made from time to time in the open market at prevailing market prices, depending on market conditions and in accordance with the applicable rules and regulations. The Company’s board of directors will review the share repurchase program periodically and may authorize adjustments to its terms and size or suspend or discontinue the share repurchase program. The Company expects to utilize its existing funds to fund repurchases made under this program.About Aesthetic Medical International Holdings Group LimitedAIH, known as “Peng’ai” in China, is a leading provider of aesthetic medical services in China. AIH operates through treatment centers that spread across major cities in mainland China, and also has presence in Hong Kong and Singapore. Leveraging over 20 years of clinical experience, AIH provides one-stop aesthetic service offerings, including surgical aesthetic treatments, non-surgical aesthetic treatments, and general medical services and other aesthetic services. According to certain third party industry consultant, AIH was the third-largest private aesthetic medical services provider in China in terms of revenue in 2018. For more information regarding the Company, please visit: http://ir.aihgroup.net/.Safe Harbor StatementThis press release contains “forward-looking statements.” These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to” and similar statements. Statements that are not historical facts, including statements about the Company’s beliefs, plans and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. These risks and uncertainties and others that relate to the Company’s business and financial condition are detailed from time to time in the Company’s SEC filings, and could cause the actual results to differ materially from those contained in any forward-looking statement. These forward-looking statements are made only as of the date indicated, and the Company undertakes no obligation to update or revise the information contained in any forward-looking statements, except as required under applicable law.Investor Relations ContactFor investor and media inquiries, please contact:Aesthetic Medical International Holdings Group LimitedEmail: ir@pengai.com.cnAscent Investor Relations LLCMs. Tina XiaoTel: (917) 609-0333Email: tina.xiao@ascent-ir.com